Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry-Reference-Cited by-同舟云学术

Novel variants in NUDT15 and thiopurine intolerance in children with acute lymphoblastic leukemia from diverse ancestry

Published:2017-09-07 Issue:10 Volume:130 Page:1209-1212
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Moriyama Takaya¹,Yang Yung-Li²,Nishii Rina¹³,Ariffin Hany⁴,Liu Chengcheng¹,Lin Ting-Nien¹,Yang Wenjian¹,Lin Dong-Tsamn²,Yu Chih-Hsiang⁵,Kham Shirley⁶,Pui Ching-Hon⁷,Evans William E.¹,Jeha Sima⁷,Relling Mary V.¹,Yeoh Allen Eng-Juh⁸⁹,Yang Jun J.¹

Affiliation:

1. Department of Pharmaceutical Sciences, St. Jude Children’s Research Hospital, Memphis, TN;

2. Department of Laboratory Medicine and Pediatrics, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan;

3. Department of Pediatrics and Developmental Biology, Tokyo Medical and Dental University Graduate School of Medicine, Tokyo, Japan;

4. Paediatric Haematology-Oncology Unit, University of Malaya Medical Centre, Kuala Lumpur, Malaysia;

5. Department of Clinical Laboratory Sciences and Medical Biotechnology, College of Medicine, National Taiwan University, Taipei, Taiwan;

6. National University Cancer Institute, National University Health System, Singapore;

7. Department of Oncology, St. Jude Children’s Research Hospital, Memphis, TN; and

8. Centre for Translational Research in Acute Leukaemia, Department of Paediatrics, Yong Loo Lin School of Medicine, and

9. Cancer Science Institute of Singapore, National University of Singapore, Singapore

Abstract

Key Points We identified 3 novel loss-of-function variants in NUDT15 linked to thiopurine intolerance. Our findings extended the importance of NUDT15 variation in thiopurine pharmacogenetics in diverse populations.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/130/10/1209/1401966/blood782383.pdf

Reference27 articles.

1. Systemic exposure to mercaptopurine as a prognostic factor in acute lymphocytic leukemia in children;Koren;N Engl J Med,1990

2. Prognostic importance of 6-mercaptopurine dose intensity in acute lymphoblastic leukemia;Relling;Blood,1999

3. Thiopurines in current medical practice: molecular mechanisms and contributions to therapy-related cancer;Karran;Nat Rev Cancer,2008

4. Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial;Vora;Lancet Oncol,2013

5. Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus;Relling;J Natl Cancer Inst,1999

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Additive effects of TPMT and NUDT15 on thiopurine toxicity in children with acute lymphoblastic leukemia across multiethnic populations;JNCI: Journal of the National Cancer Institute;2024-01-16

2. Measurement of the intracellular active metabolites of thiopurine drugs to evaluate the enzymatic activity of nudix hydrolase 15 in human blood samples;Journal of Chromatography B;2024-01

3. Kinetic and structural characterization of human NUDIX hydrolases NUDT15 and NUDT18 as catalysts of isoprene pyrophosphate hydrolysis;2023-11-29

4. Individualized Use of 6‐Mercaptopurine in Chinese Children with ALL: A Multicenter Randomized Controlled Trial;Clinical Pharmacology & Therapeutics;2023-10-16

5. Pharmacogenetics of 6-mercaptopurine in a black Zimbabwean cohort treated for acute lymphoblastic leukaemia;Pharmacogenomics;2023-06